Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06135324 · ClinicalTrials.gov registry record

Impairments That Affect Correct Inhaler Use in COPD

A clinical trial of COPD, sponsored by COPD Foundation.

Active
Registry status
500
Enrollment target
9
Study locations

NCT06135324 is a study of COPD that is active but no longer recruiting, run by COPD Foundation. The registered enrollment target is 500 participants, below the 2,412-participant average among 85 other COPD trials with a reported enrollment target (79% lower). The trial reports 9 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06135324, a study of COPD, is active but no longer recruiting, sponsored by COPD Foundation.

ACTIVE NOT RECRUITING
Registry status
500 participants
Enrollment target
9
Study locations

Study Summary

INHALE is a one-year, multi-site observational research study funded by Viatris, with two aims: 1. Determine the prevalence of both cognitive impairment and impaired manual dexterity in stable out-patients with chronic obstructive pulmonary disease (COPD). 2. Assess the relationship of cognitive impairment and impaired manual dexterity with patient errors using current pMDIs, SMIs and/or DPIs.

Conditions Studied

Study Locations (9)

Alabama

  • University of Alabama at Birmingham - Lung Health Center - Birmingham

Illinois

  • RUSH University - Chicago

Massachusetts

  • Lahey Clinic, Inc. - Burlington

Missouri

  • Midwest Chest Consultants, PC - Saint Charles

New Hampshire

  • Valley Regional Hospital - Claremont

North Carolina

  • Atrium Health Wake Forest Baptist - Winston-Salem

Pennsylvania

  • University of Pittsburgh Medical Center - Pittsburgh

Tennessee

  • Erlanger Health - Chattanooga

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2023-12-14
Est. Completion 2025-10-31

Sponsor

COPD Foundation

5 total trials

What the Registry Record Tells You About NCT06135324

The ClinicalTrials.gov registry entry for NCT06135324 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,412-participant average among 85 other COPD trials with a reported enrollment target (79% lower). The listed sponsor is COPD Foundation, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with COPD appearing as the primary indexed condition, and to 0 interventions.

NCT06135324 reports 9 study locations spanning 9 distinct geographic areas - top geographies include Alabama, Illinois, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06135324 about?

NCT06135324 is a clinical study titled "Impairments That Affect Correct Inhaler Use in COPD". INHALE is a one-year, multi-site observational research study funded by Viatris, with two aims: 1. Determine the prevalence of both cognitive impairment and impaired manual dexterity in stable out-patients with chronic obstructive pulmonary disease (COPD). 2. Assess the relationship of cognitive im...

What is the current status of trial NCT06135324?

This trial is currently active not recruiting. The enrollment target is 500 participants. The study started on 2023-12-14. Estimated completion is 2025-10-31.

What conditions does trial NCT06135324 study?

This clinical trial studies the following conditions: COPD.

Who is sponsoring clinical trial NCT06135324?

This trial is sponsored by COPD Foundation, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06135324 being conducted?

This trial has 9 study locations across Alabama, Illinois, Massachusetts, Missouri, New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COPD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.